|
 |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Wednesday 31 October 2007 |
 Forward to a colleague |
|
|
Access Full Stories  Chemical trigger of Parkinson's foundA group of scientists believe they have cracked the riddle of how Parkinson's disease is triggered - a breakthrough that could lead to more effective therapies against the disease... Read Imaging the 'spectroscopic signature of life' Japanese researchers have used an advanced microspectroscopy technique to study the cell cycle of yeast without the need for fluorescent imaging agents that can potentially alter the cellular environment... Read Covance posts healthy 3Q growth Covance is feeling positive after reporting healthy growth in both business units for the third quarter, with its early phase segment continuing to have the edge over its late stage unit... Read Nycomed to acquire Bradley Nycomed is to acquire Bradley Pharmaceuticals for $346m (€240m) in a bid to make a niche for itself in the dermatology market... Read Drugs moving into the clinic: 33 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
|
|||||||||||||||
All News Headlines for: October | September | August |
|||||||||||||||||
 Product BrochureHave you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here | |||||||||||||||||
|
|||||||||||||||||
|
Related Industry News Premature ejaculation spray coming to clinical climax A nifty spray-on solution could make all the difference for men plagued with problem of climaxing too soon, as the product makes its final thrust in clinical development... Read Pharmaceutical manufacturing: people on the move Pfizer, Savient Pharmaceuticals, Teva Pharmaceuticals, NPS Pharmaceuticals and MicroCHIPS have all had people on the move in the world of pharmaceutical manufacturing... Read Once-weekly diabetes treatment looking good A once-weekly Type II diabetes treatment has shown promise when compared to its twice-daily counterpart... Read Karma for big pharma? Sanofi-Aventis caught out by Inyx collapse Sanofi-Aventis has had to take Inyx USA to court after it failed to deliver on a contract manufacturing and supply agreement, a situation that Aventis feared could "seriously harm its interests". There may be important... Read
|
|||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
